Maat Pharma SA
PAR:MAAT
Relative Value
The Relative Value of one MAAT stock under the Base Case scenario is 1.9 EUR. Compared to the current market price of 8 EUR, Maat Pharma SA is Overvalued by 76%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.